Detalhe da pesquisa
1.
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.
Int J Mol Sci
; 19(9)2018 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30149597
2.
PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors.
Mol Carcinog
; 54(7): 566-76, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24347284
3.
EZH2 in Bladder Cancer, a Promising Therapeutic Target.
Int J Mol Sci
; 16(11): 27107-32, 2015 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26580594
4.
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.
Cell Death Discov
; 10(1): 1, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172127
5.
CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies.
Front Immunol
; 14: 1272681, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854601
6.
Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma.
Cancers (Basel)
; 15(6)2023 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980757
7.
Colorectal Cancer Stem Cells Fuse with Monocytes to Form Tumour Hybrid Cells with the Ability to Migrate and Evade the Immune System.
Cancers (Basel)
; 14(14)2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884505
8.
Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer.
Cancers (Basel)
; 14(2)2022 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053540
9.
Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder Cancer.
Cancers (Basel)
; 14(2)2022 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053451
10.
Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.
Clin Epigenetics
; 13(1): 63, 2021 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761971
11.
Acquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report.
Clin Case Rep
; 9(3): 1304-1306, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33768832
12.
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.
Front Oncol
; 11: 744112, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34804931
13.
Gene expression profiling of mouse p53-deficient epidermal carcinoma defines molecular determinants of human cancer malignancy.
Mol Cancer
; 9: 193, 2010 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20630075
14.
Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies.
Front Oncol
; 10: 1774, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33042825
15.
Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma.
In Vivo
; 23(5): 653-60, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19779097
16.
Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status.
Sci Rep
; 9(1): 10362, 2019 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31316092
17.
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet.
Front Genet
; 10: 1125, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31850055
18.
CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status.
Clin Cancer Res
; 25(1): 390-402, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30242024
19.
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
Nat Med
; 25(7): 1073-1081, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31270502
20.
Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
Oral Oncol
; 79: 55-63, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29598951